TreeWAS – Variant ID: rs6904416

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T39.0 Salicylates	0.052	0.948	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.044	0.956	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.043	0.957	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.036	0.964	0.000
T39.4 Antirheumatics, not elsewhere classified	0.032	0.968	0.000
T39.2 Pyrazolone derivatives	0.032	0.968	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.031	0.969	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.027	0.973	0.000
T39.1 4-Aminophenol derivatives	0.026	0.974	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.022	0.978	0.000
G31.0 Circumscribed brain atrophy	0.018	0.981	0.000
G31.8 Other specified degenerative diseases of nervous system	0.018	0.982	0.000
G31.2 Degeneration of nervous system due to alcohol	0.016	0.983	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.016	0.984	0.000
Z75.1 Person awaiting admission to adequate facility elsewhere	0.000	0.987	0.013
G30-G32 Other degenerative diseases of the nervous system	0.012	0.988	0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.000	0.988	0.012
Y52.4 Angiotensin-converting-enzyme inhibitors	0.012	0.988	0.000
G30 Alzheimer's disease	0.010	0.990	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.010	0.990	0.000
Y52 Agents primarily affecting the cardiovascular system	0.010	0.990	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.010	0.990	0.000
T36.0 Penicillins	0.009	0.991	0.000
G30.0 Alzheimer's disease with early onset	0.009	0.991	0.000
M41.99 Scoliosis, unspecified (Site unspecified)	0.000	0.991	0.009
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.008	0.991	0.000
T36 Poisoning by systemic antibiotics	0.008	0.992	0.000
G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere	0.008	0.992	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.008	0.992	0.000
Y52.1 Calcium-channel blockers	0.008	0.992	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.008	0.992	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.008	0.992	0.000
G30.8 Other Alzheimer's disease	0.008	0.992	0.000
G30.1 Alzheimer's disease with late onset	0.007	0.992	0.000
G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere	0.007	0.993	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.007	0.993	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.007	0.993	0.000
Y52.7 Peripheral vasodilators	0.007	0.993	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.993	0.007
Z75 Problems related to medical facilities and other health care	0.000	0.993	0.007
Z50.5 Speech therapy	0.000	0.993	0.007
Z50 Care involving use of rehabilitation procedures	0.000	0.993	0.007
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.007	0.993	0.000
M41.9 Scoliosis, unspecified	0.000	0.993	0.007
Z75.2 Other waiting period for investigation and treatment	0.000	0.994	0.006
T36.9 Systemic antibiotic, unspecified	0.006	0.994	0.000
T36.8 Other systemic antibiotics	0.006	0.994	0.000
T36.7 Antifungal antibiotics, systemically used	0.006	0.994	0.000
T36.6 Rifamycins	0.006	0.994	0.000
T36.5 Aminoglycosides	0.006	0.994	0.000
T36.4 Tetracyclines	0.006	0.994	0.000
T36.3 Macrolides	0.006	0.994	0.000
T36.2 Chloramphenicol group	0.006	0.994	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.006	0.994	0.000
S06.2 Diffuse brain injury	0.000	0.994	0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.006	0.994	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.006	0.994	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.006	0.994	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.006	0.994	0.000
G30.9 Alzheimer's disease, unspecified	0.006	0.994	0.000
S42.30 Fracture of shaft of humerus (closed)	0.000	0.994	0.006
Z75.8 Other problems related to medical facilities and other health care	0.000	0.994	0.006
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.994	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.006	0.994	0.000
G50.0 Trigeminal neuralgia	0.000	0.994	0.006
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.006	0.994	0.000
Z75.4 Unavailability and inaccessibility of other helping agencies	0.000	0.994	0.006
Z50.2 Alcohol rehabilitation	0.000	0.994	0.006
M41.96 Scoliosis, unspecified (Lumbar region)	0.000	0.994	0.006
T45.2 Vitamins, not elsewhere classified	0.006	0.994	0.000
C80.9 Malignant neoplasm, unspecified	0.006	0.994	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.006	0.994	0.000
Z75.9 Unspecified problem related to medical facilities and other health care	0.000	0.994	0.005
Z75.0 Medical services not available in home	0.000	0.994	0.005
W22.9 Unspecified place	0.000	0.994	0.006
S06 Intracranial injury	0.000	0.995	0.005
Z50.1 Other physical therapy	0.000	0.995	0.005
Z75.5 Holiday relief care	0.000	0.995	0.005
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.000	0.995	0.005
S06.5 Traumatic subdural haemorrhage	0.000	0.995	0.005
T42.1 Iminostilbenes	0.005	0.995	0.000
Z75.3 Unavailability and inaccessibility of health-care facilities	0.000	0.995	0.005
Z50.6 Orthoptic training	0.000	0.995	0.005
Z50.3 Drug rehabilitation	0.000	0.995	0.005
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.995	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.995	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.995	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.995	0.000
T45.4 Iron and its compounds	0.005	0.995	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.000	0.995	0.005
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.995	0.005
T47.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.995	0.005
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.000	0.995	0.005
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.000	0.995	0.005
M41.92 Scoliosis, unspecified (Cervical region)	0.000	0.995	0.005
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.000	0.995	0.005
C80 Malignant neoplasm without specification of site	0.005	0.995	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.000	0.995	0.005
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.005	0.995	0.000
Z50.8 Care involving use of rehabilitation procedures	0.000	0.995	0.005
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.000	0.995	0.005
S06.21 Diffuse brain injury (with open intracranial wound)	0.000	0.995	0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.005	0.995	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.005	0.995	0.000
T42.3 Barbiturates	0.005	0.995	0.000
T42.2 Succinimides and oxazolidinediones	0.005	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
T47.7 Emetics	0.005	0.995	0.000
T47.6 Antidiarrhoeal drugs	0.005	0.995	0.000
T47.5 Digestants	0.005	0.995	0.000
T47.4 Other laxatives	0.005	0.995	0.000
T47.3 Saline and osmotic laxatives	0.005	0.995	0.000
T47.2 Stimulant laxatives	0.005	0.995	0.000
T47.0 Histamine H(2)-receptor antagonists	0.005	0.995	0.000
T42.0 Hydantoin derivatives	0.005	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.995	0.000
S06.4 Epidural haemorrhage	0.000	0.995	0.005
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.995	0.000
Z29.0 Isolation	0.005	0.995	0.000
T45.5 Anticoagulants	0.004	0.995	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.995	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.995	0.000
T37.5 Antiviral drugs	0.004	0.995	0.000
T37.4 Anthelminthics	0.004	0.995	0.000
T37.3 Other antiprotozoal drugs	0.004	0.995	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.995	0.000
T37.1 Antimycobacterial drugs	0.004	0.995	0.000
T37.0 Sulphonamides	0.004	0.995	0.000
T41.5 Therapeutic gases	0.004	0.995	0.000
T41.4 Anaesthetic, unspecified	0.004	0.995	0.000
T41.3 Local anaesthetics	0.004	0.995	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.995	0.000
T41.1 Intravenous anaesthetics	0.004	0.995	0.000
T41.0 Inhaled anaesthetics	0.004	0.995	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.995	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.995	0.000
T48.5 Anti-common-cold drugs	0.004	0.995	0.000
T48.4 Expectorants	0.004	0.995	0.000
T48.3 Antitussives	0.004	0.995	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.995	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.995	0.000
T48.0 Oxytocic drugs	0.004	0.995	0.000
T49.9 Topical agent, unspecified	0.004	0.995	0.000
T49.8 Other topical agents	0.004	0.995	0.000
T49.7 Dental drugs, topically applied	0.004	0.995	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.995	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.995	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.995	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.995	0.000
T49.2 Local astringents and local detergents	0.004	0.995	0.000
T49.1 Antipruritics	0.004	0.995	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.995	0.000
S06.8 Other intracranial injuries	0.000	0.996	0.004
Z29.2 Other prophylactic chemotherapy	0.004	0.996	0.000
L53.9 Erythematous condition, unspecified	0.000	0.996	0.004
S06.9 Intracranial injury, unspecified	0.000	0.996	0.004
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.996	0.004
S06.0 Concussion	0.000	0.996	0.004
S06.7 Intracranial injury with prolonged coma	0.000	0.996	0.004
S06.1 Traumatic cerebral oedema	0.000	0.996	0.004
Z29 Need for other prophylactic measures	0.004	0.996	0.000
S06.40 Epidural haemorrhage (without open intracranial wound)	0.000	0.996	0.004
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.000	0.996	0.004
S06.3 Focal brain injury	0.000	0.996	0.004
K52.9 Non-infective gastro-enteritis and colitis, unspecified	0.004	0.996	0.000
M41 Scoliosis	0.000	0.996	0.004
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
T38.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
T38.7 Androgens and anabolic congeners	0.004	0.996	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.004	0.996	0.000
T38.5 Other oestrogens and progestogens	0.004	0.996	0.000
T38.4 Oral contraceptives	0.004	0.996	0.000
T38.2 Antithyroid drugs	0.004	0.996	0.000
T38.0 Glucocorticoids and synthetic analogues	0.004	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.004	0.996	0.000
Z29.1 Prophylactic immunotherapy	0.004	0.996	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.000	0.996	0.004
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.996	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.996	0.004
W22 Striking against or struck by other objects	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.996	0.000
T50.8 Diagnostic agents	0.003	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.996	0.000
T50.5 Appetite depressants	0.003	0.996	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.996	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.996	0.000
S06.41 Epidural haemorrhage (with open intracranial wound)	0.000	0.996	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.996	0.000
T46.7 Peripheral vasodilators	0.003	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.996	0.000
T46.1 Calcium-channel blockers	0.003	0.996	0.000
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.000	0.996	0.003
S06.81 Other intracranial injuries (with open intracranial wound)	0.000	0.997	0.003
S06.91 Intracranial injury, unspecified (with open intracranial wound)	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
S06.00 Concussion (without open intracranial wound)	0.000	0.997	0.003
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.997	0.003
S06.01 Concussion (with open intracranial wound)	0.000	0.997	0.003
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.000	0.997	0.003
W22.2 School, other institution and public administrative area	0.000	0.997	0.003
S06.11 Traumatic cerebral oedema (with open intracranial wound)	0.000	0.997	0.003
S06.10 Traumatic cerebral oedema (without open intracranial wound)	0.000	0.997	0.003
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)	0.000	0.997	0.003
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)	0.000	0.997	0.003
M41.8 Other forms of scoliosis	0.000	0.997	0.003
C17.9 Small intestine, unspecified	0.003	0.997	0.000
Z29.9 Prophylactic measure, unspecified	0.003	0.997	0.000
W22.5 Trade and service area	0.000	0.997	0.003
S06.31 Focal brain injury (with open intracranial wound)	0.000	0.997	0.003
M41.5 Other secondary scoliosis	0.000	0.997	0.003
M41.4 Neuromuscular scoliosis	0.000	0.997	0.003
M41.3 Thoracogenic scoliosis	0.000	0.997	0.003
M41.2 Other idiopathic scoliosis	0.000	0.997	0.003
M41.1 Juvenile idiopathic scoliosis	0.000	0.997	0.003
M41.0 Infantile idiopathic scoliosis	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.997	0.003
M23.04 Cystic meniscus (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.003	0.997	0.000
S42.3 Fracture of shaft of humerus	0.000	0.997	0.003
H53.8 Other visual disturbances	0.003	0.997	0.000
W22.8 Other specified place	0.000	0.997	0.003
W22.6 Industrial and construction area	0.000	0.997	0.003
W22.4 Street and highway	0.000	0.997	0.003
W22.0 Home	0.000	0.997	0.003
W22.7 Farm	0.000	0.997	0.003
W22.3 Sports and athletics area	0.000	0.997	0.003
W22.1 Residential institution	0.000	0.997	0.003
E87.1 Hypo-osmolality and hyponatraemia	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
M41.86 Other forms of scoliosis (Lumbar region)	0.000	0.997	0.003
M23.03 Cystic meniscus (Medial collateral ligament or Other and unspecified medial meniscus)	0.003	0.997	0.000
Z29.8 Other specified prophylactic measures	0.003	0.997	0.000
M41.89 Other forms of scoliosis (Site unspecified)	0.000	0.997	0.002
M41.88 Other forms of scoliosis (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M41.87 Other forms of scoliosis (Lumbosacral region)	0.000	0.997	0.002
M41.85 Other forms of scoliosis (Thoracolumbar region)	0.000	0.997	0.002
M41.84 Other forms of scoliosis (Thoracic region)	0.000	0.997	0.002
M41.83 Other forms of scoliosis (Cervicothoracic region)	0.000	0.997	0.002
M41.82 Other forms of scoliosis (Cervical region)	0.000	0.997	0.002
M41.81 Other forms of scoliosis (Occipito-atlanto-axial region)	0.000	0.997	0.002
M41.80 Other forms of scoliosis (Multiple sites in spine)	0.000	0.997	0.002
H93.1 Tinnitus	0.000	0.997	0.003
T42.4 Benzodiazepines	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
J39.8 Other specified diseases of upper respiratory tract	0.000	0.997	0.003
M41.09 Infantile idiopathic scoliosis (Site unspecified)	0.000	0.997	0.002
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)	0.000	0.997	0.002
M41.06 Infantile idiopathic scoliosis (Lumbar region)	0.000	0.997	0.002
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)	0.000	0.997	0.002
M41.04 Infantile idiopathic scoliosis (Thoracic region)	0.000	0.997	0.002
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)	0.000	0.997	0.002
M41.02 Infantile idiopathic scoliosis (Cervical region)	0.000	0.997	0.002
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)	0.000	0.997	0.002
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)	0.000	0.997	0.002
M41.19 Juvenile idiopathic scoliosis (Site unspecified)	0.000	0.997	0.002
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)	0.000	0.997	0.002
M41.16 Juvenile idiopathic scoliosis (Lumbar region)	0.000	0.997	0.002
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)	0.000	0.997	0.002
M41.14 Juvenile idiopathic scoliosis (Thoracic region)	0.000	0.997	0.002
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)	0.000	0.997	0.002
M41.12 Juvenile idiopathic scoliosis (Cervical region)	0.000	0.997	0.002
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)	0.000	0.997	0.002
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)	0.000	0.997	0.002
M41.29 Other idiopathic scoliosis (Site unspecified)	0.000	0.997	0.002
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M41.27 Other idiopathic scoliosis (Lumbosacral region)	0.000	0.997	0.002
M41.26 Other idiopathic scoliosis (Lumbar region)	0.000	0.997	0.002
M41.25 Other idiopathic scoliosis (Thoracolumbar region)	0.000	0.997	0.002
M41.24 Other idiopathic scoliosis (Thoracic region)	0.000	0.997	0.002
M41.23 Other idiopathic scoliosis (Cervicothoracic region)	0.000	0.997	0.002
M41.22 Other idiopathic scoliosis (Cervical region)	0.000	0.997	0.002
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)	0.000	0.997	0.002
M41.20 Other idiopathic scoliosis (Multiple sites in spine)	0.000	0.997	0.002
M41.39 Thoracogenic scoliosis-Site unspe	0.000	0.997	0.002
M41.38 Thoracogenic scoliosis-Sacral/sacrococ	0.000	0.997	0.002
M41.37 Thoracogenic scoliosis-Lumbosacral	0.000	0.997	0.002
M41.36 Thoracogenic scoliosis-Lumbar	0.000	0.997	0.002
M41.35 Thoracogenic scoliosis (Thoracolumbar region)	0.000	0.997	0.002
M41.34 Thoracogenic scoliosis (Thoracic region)	0.000	0.997	0.002
M41.33 Thoracogenic scoliosis (Cervicothoracic region)	0.000	0.997	0.002
M41.32 Thoracogenic scoliosis-Cervical	0.000	0.997	0.002
M41.31 Thoracogenic scoliosis-Occipit-atl-axl	0.000	0.997	0.002
M41.30 Thoracogenic scoliosis (Multiple sites in spine)	0.000	0.997	0.002
M41.49 Neuromuscular scoliosis (Site unspecified)	0.000	0.997	0.002
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M41.47 Neuromuscular scoliosis (Lumbosacral region)	0.000	0.997	0.002
M41.46 Neuromuscular scoliosis (Lumbar region)	0.000	0.997	0.002
M41.45 Neuromuscular scoliosis (Thoracolumbar region)	0.000	0.997	0.002
M41.44 Neuromuscular scoliosis (Thoracic region)	0.000	0.997	0.002
M41.43 Neuromuscular scoliosis (Cervicothoracic region)	0.000	0.997	0.002
M41.42 Neuromuscular scoliosis (Cervical region)	0.000	0.997	0.002
M41.41 Neuromuscular scoliosis (Occipito-atlanto-axial region)	0.000	0.997	0.002
M41.40 Neuromuscular scoliosis (Multiple sites in spine)	0.000	0.997	0.002
M41.59 Other secondary scoliosis (Site unspecified)	0.000	0.997	0.002
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M41.57 Other secondary scoliosis (Lumbosacral region)	0.000	0.997	0.002
M41.56 Other secondary scoliosis (Lumbar region)	0.000	0.997	0.002
M41.55 Other secondary scoliosis (Thoracolumbar region)	0.000	0.997	0.002
M41.54 Other secondary scoliosis (Thoracic region)	0.000	0.997	0.002
M41.53 Other secondary scoliosis (Cervicothoracic region)	0.000	0.997	0.002
M41.52 Other secondary scoliosis (Cervical region)	0.000	0.997	0.002
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)	0.000	0.997	0.002
M41.50 Other secondary scoliosis (Multiple sites in spine)	0.000	0.997	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.997	0.000
T40.8 Lysergide [LSD]	0.002	0.997	0.000
T40.7 Cannabis (derivatives)	0.002	0.997	0.000
T40.5 Cocaine	0.002	0.997	0.000
T40.3 Methadone	0.002	0.997	0.000
T40.1 Heroin	0.002	0.997	0.000
T40.0 Opium	0.002	0.997	0.000
I44.2 Atrioventricular block, complete	0.002	0.998	0.000
N72 Inflammatory disease of cervix uteri	0.002	0.998	0.000
W22.09 Striking against or struck by other objects; Home; During unspecified activity	0.000	0.998	0.002
W22.03 Striking against or struck by other objects; Home; While engaged in other types of work	0.000	0.998	0.002
W22.41 Striking against or struck by other objects; Street and highway;While engaged in leisure activity	0.000	0.998	0.002
W22.62 Striking against or struck by other objects; Industrial and construction area ;While working for income	0.000	0.998	0.002
W22.88 Striking against or struck by other objects; Other specified places ;While engaged in other specified activities	0.000	0.998	0.002
S82.40 Fracture of fibula alone (closed)	0.000	0.998	0.002
M23.0 Cystic meniscus	0.002	0.998	0.000
Z50.0 Cardiac rehabilitation	0.000	0.998	0.002
J18.0 Bronchopneumonia, unspecified	0.002	0.998	0.000
G50 Disorders of trigeminal nerve	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
S42.31 Fracture of shaft of humerus (open)	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.998	0.002
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.998	0.002
M93.9 Osteochondropathy, unspecified	0.002	0.998	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.998	0.002
M23.09 Cystic meniscus (Unspecified ligament or Unspecified meniscus)	0.002	0.998	0.000
F20.9 Schizophrenia, unspecified	0.002	0.998	0.000
T83.1 Mechanical complication of other urinary devices and implants	0.002	0.998	0.000
K60.1 Chronic anal fissure	0.002	0.998	0.000
M23.07 Cystic meniscus-Capsular lig	0.002	0.998	0.000
M23.05 Cystic meniscus (Posterior horn of lateral meniscus)	0.002	0.998	0.000
M23.02 Cystic meniscus (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.002	0.998	0.000
M23.01 Cystic meniscus (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
M23.00 Cystic meniscus (Multiple sites)	0.002	0.998	0.000
A04.5 Campylobacter enteritis	0.000	0.998	0.002
R22.2 Localised swelling, mass and lump, trunk	0.000	0.998	0.002
M23.06 Cystic meniscus (Other and unspecified lateral meniscus)	0.002	0.998	0.000
T51.9 Alcohol, unspecified	0.002	0.998	0.000
G50.8 Other disorders of trigeminal nerve	0.000	0.998	0.002
I69.3 Sequelae of cerebral infarction	0.000	0.998	0.002
G50.9 Disorder of trigeminal nerve, unspecified	0.000	0.998	0.002
N61 Inflammatory disorders of breast	0.002	0.998	0.000
I67.9 Cerebrovascular disease, unspecified	0.000	0.998	0.002
W18.5 Trade and service area	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.001	0.998	0.001
O36.8 Maternal care for other specified foetal problems	0.000	0.998	0.002
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.001
H01.0 Blepharitis	0.000	0.998	0.002
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.998	0.002
K55.0 Acute vascular disorders of intestine	0.000	0.998	0.002
M40-M43 Deforming dorsopathies	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.001	0.998	0.001
S42.00 Fracture of clavicle (closed)	0.000	0.998	0.002
G50.1 Atypical facial pain	0.000	0.998	0.001
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
N42.8 Other specified disorders of prostate	0.002	0.998	0.000
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.000	0.998	0.002
L53 Other erythematous conditions	0.000	0.998	0.001
T79.6 Traumatic ischaemia of muscle	0.000	0.998	0.001
T79.3 Post-traumatic wound infection, not elsewhere classified	0.000	0.998	0.001
I69 Sequelae of cerebrovascular disease	0.000	0.998	0.002
M43.1 Spondylolisthesis	0.000	0.999	0.001
O72.2 Delayed and secondary postpartum haemorrhage	0.000	0.999	0.001
C17.1 Jejunum	0.001	0.999	0.000
C50.8 Overlapping lesion of breast	0.000	0.999	0.001
G44.4 Drug-induced headache, not elsewhere classified	0.001	0.999	0.000
S64.3 Injury of digital nerve of thumb	0.001	0.999	0.000
C07 Malignant neoplasm of parotid gland	0.001	0.999	0.000
M43 Other deforming dorsopathies	0.000	0.999	0.001
C17 Malignant neoplasm of small intestine	0.001	0.999	0.000
M42 Spinal osteochondrosis	0.000	0.999	0.001
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.001	0.999	0.000
T43.9 Psychotropic drug, unspecified	0.001	0.999	0.001
T43.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.001
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.001
G54.9 Nerve root and plexus disorder, unspecified	0.000	0.999	0.001
T43.6 Psychostimulants with abuse potential	0.001	0.999	0.001
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.000	0.999	0.001
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.999	0.001
L53.3 Other chronic figurate erythema	0.000	0.999	0.001
L53.2 Erythema marginatum	0.000	0.999	0.001
L53.1 Erythema annulare centrifugum	0.000	0.999	0.001
U80.1 Methicillin resistant agent	0.000	0.999	0.001
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.000	0.999	0.001
G54.0 Brachial plexus disorders	0.000	0.999	0.001
J86.9 Pyothorax without fistula	0.001	0.999	0.000
S42.0 Fracture of clavicle	0.000	0.999	0.001
T43.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.001
Z48.9 Surgical follow-up care, unspecified	0.001	0.999	0.000
M22.4 Chondromalacia patellae	0.000	0.999	0.001
S09.8 Other specified injuries of head	0.000	0.999	0.001
T40.2 Other opioids	0.001	0.999	0.000
T43.2 Other and unspecified antidepressants	0.000	0.999	0.001
Z76.9 Persons encountering health services in unspecified circumstances	0.000	0.999	0.001
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.999	0.001
K60.5 Anorectal fistula	0.001	0.999	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.001	0.999	0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M43.15 Spondylolisthesis (Thoracolumbar region)	0.000	0.999	0.001
M43.14 Spondylolisthesis (Thoracic region)	0.000	0.999	0.001
M43.13 Spondylolisthesis (Cervicothoracic region)	0.000	0.999	0.001
M43.12 Spondylolisthesis (Cervical region)	0.000	0.999	0.001
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.000	0.999	0.001
M43.10 Spondylolisthesis (Multiple sites in spine)	0.000	0.999	0.001
W21.9 Unspecified place	0.000	0.999	0.001
Z20 Contact with and exposure to communicable diseases	0.001	0.999	0.000
E80.4 Gilbert's syndrome	0.001	0.999	0.000
M42.9 Spinal osteochondrosis, unspecified	0.000	0.999	0.001
M42.1 Adult osteochondrosis of spine	0.000	0.999	0.001
M42.0 Juvenile osteochondrosis of spine	0.000	0.999	0.001
M43.9 Deforming dorsopathy, unspecified	0.000	0.999	0.001
M43.8 Other specified deforming dorsopathies	0.000	0.999	0.001
M43.5 Other recurrent vertebral subluxation	0.000	0.999	0.001
M43.4 Other recurrent atlantoaxial subluxation	0.000	0.999	0.001
M43.3 Recurrent atlantoaxial subluxation with myelopathy	0.000	0.999	0.001
M43.2 Other fusion of spine	0.000	0.999	0.001
B02.2 Zoster with other nervous system involvement	0.000	0.999	0.001
C17.8 Overlapping lesion of small intestine	0.001	0.999	0.000
C17.3 Meckel's diverticulum	0.001	0.999	0.000
C17.2 Ileum	0.001	0.999	0.000
H80.9 Otosclerosis, unspecified	0.000	0.999	0.001
L53.0 Toxic erythema	0.000	0.999	0.001
Z28 Immunisation not carried out	0.001	0.999	0.000
Z27 Need for immunisation against combinations of infectious diseases	0.001	0.999	0.000
Z26 Need for immunisation against other single infectious diseases	0.001	0.999	0.000
Z25 Need for immunisation against other single viral diseases	0.001	0.999	0.000
Z24 Need for immunisation against certain single viral diseases	0.001	0.999	0.000
Z23 Need for immunisation against single bacterial diseases	0.001	0.999	0.000
G91.9 Hydrocephalus, unspecified	0.001	0.999	0.000
H25.8 Other senile cataract	0.001	0.999	0.000
C66 Malignant neoplasm of ureter	0.001	0.999	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.999	0.001
S42.01 Fracture of clavicle (open)	0.000	0.999	0.001
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.999	0.001
M40 Kyphosis and lordosis	0.000	0.999	0.001
M43.0 Spondylolysis	0.000	0.999	0.001
X62.9 Unspecified place	0.001	0.999	0.000
Z20.8 Contact with and exposure to other communicable diseases	0.001	0.999	0.000
M14.6 Neuropathic arthropathy	0.000	0.999	0.001
N95.8 Other specified menopausal and perimenopausal disorders	0.000	0.999	0.001
O69.2 Labour and delivery complicated by other cord entanglement	0.000	0.999	0.001
T21.3 Burn of third degree of trunk	0.001	0.999	0.000
Z20.9 Contact with and exposure to unspecified communicable disease	0.001	0.999	0.000
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations	0.001	0.999	0.000
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]	0.001	0.999	0.000
Z20.5 Contact with and exposure to viral hepatitis	0.001	0.999	0.000
Z20.4 Contact with and exposure to rubella	0.001	0.999	0.000
Z20.3 Contact with and exposure to rabies	0.001	0.999	0.000
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission	0.001	0.999	0.000
Z20.1 Contact with and exposure to tuberculosis	0.001	0.999	0.000
Z20.0 Contact with and exposure to intestinal infectious diseases	0.001	0.999	0.000
M42.09 Juvenile osteochondrosis of spine (Site unspecified)	0.000	0.999	0.001
M42.08 Juvenile osteochondrosis of spine (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M42.07 Juvenile osteochondrosis of spine (Lumbosacral region)	0.000	0.999	0.001
M42.06 Juvenile osteochondrosis of spine (Lumbar region)	0.000	0.999	0.001
M42.05 Juvenile osteochondrosis of spine (Thoracolumbar region)	0.000	0.999	0.001
M42.04 Juvenile osteochondrosis of spine (Thoracic region)	0.000	0.999	0.001
M42.03 Juvenile osteochondrosis of spine (Cervicothoracic region)	0.000	0.999	0.001
M42.02 Juvenile osteochondrosis of spine (Cervical region)	0.000	0.999	0.001
M42.01 Juvenile osteochondrosis of spine (Occipito-atlanto-axial region)	0.000	0.999	0.001
M42.00 Juvenile osteochondrosis of spine (Multiple sites in spine)	0.000	0.999	0.001
M42.19 Adult osteochondrosis of spine (Site unspecified)	0.000	0.999	0.001
M42.18 Adult osteochondrosis of spine (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M42.17 Adult osteochondrosis of spine (Lumbosacral region)	0.000	0.999	0.001
M42.16 Adult osteochondrosis of spine (Lumbar region)	0.000	0.999	0.001
M42.15 Adult osteochondrosis of spine (Thoracolumbar region)	0.000	0.999	0.001
M42.14 Adult osteochondrosis of spine (Thoracic region)	0.000	0.999	0.001
M42.13 Adult osteochondrosis of spine (Cervicothoracic region)	0.000	0.999	0.001
M42.12 Adult osteochondrosis of spine (Cervical region)	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations